[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:connective-tissue-disease-associated-pulmonary-arterial-hypertension":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":23,"states":24},"Connective Tissue Disease-Associated Pulmonary Arterial Hypertension",2,1,[8,15],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT05462574","Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)",[],"RECRUITING","2026-08-26T02:17:48.768272Z","2026-05-13T02:55:06.350126Z",{"nct_id":16,"title":17,"phases":18,"status":20,"updated_at":21,"content_modified":22},"NCT03683186","A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension",[19],"Phase 3","ENROLLING_BY_INVITATION","2026-08-26T02:18:24.494016Z","2026-06-16T05:54:07.969216Z",[],[]]